Method Evaluation

CLSI FDA Approval Webinar

Streamline the FDA Approval Journey: A Panel Discussion with the FDA, CLSI, and Abbott Laboratories

The appropriate use of consensus standards can greatly streamline FDA medical device submissions and reduce the burden for the conformity assessment elements. With appropriate use of FDA-recognized consensus standards, developers of devices and LDTs can submit declarations of conformity (DOC) to meet premarket requirements and reduce the amount of supporting data and information that are submitted to the FDA.

Speakers from each area will each present information on the development and/or use of standards from their perspective:

Clinical and Laboratory Standards Institute (CLSI), for standards development process and standards available to industry. 
FDA, for the appropriate use of standards. 
Abbott, for the industry perspective on participation in standards development. 

August 28, 2024
1.00

{{FormatPrice(currentPrice)}}

Free

{{FormatPrice(nonMemberPrice)}} List Price
This is your member pricing.
Notify Me About New Editions
Scope

Learning Objectives

  1. Identify how the use of FDA-Recognized Standards can reduce the documentation burden of regulatory submissions.
  2. Determine how to use consensus standards effectively, including the submission of a Declaration of Conformity to the FDA. 
  3. Summarize how participation in standards development is essential to ensuring that consensus standards incorporate regulatory needs. 

Basic: Entry level. No prior knowledge of subject necessary.

CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

Speakers
Barb Jones, PhD, CEO, CLSI
Terry Woods, PhD, Director, Division of Standards and Conformity Assessment (DSCA), FDA
Vicki Petrides, MS, Quality Program Manager, Abbott
Supporting Resources
CLSI EP10IG
Preliminary Evaluation of Quantitative Medical Laboratory Measurement Procedures Implementation Guide
Companion
Method Evaluation
Free
Scope

Learning Objectives

  1. Identify how the use of FDA-Recognized Standards can reduce the documentation burden of regulatory submissions.
  2. Determine how to use consensus standards effectively, including the submission of a Declaration of Conformity to the FDA. 
  3. Summarize how participation in standards development is essential to ensuring that consensus standards incorporate regulatory needs. 

Basic: Entry level. No prior knowledge of subject necessary.

CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

Speakers
Barb Jones, PhD, CEO, CLSI
Terry Woods, PhD, Director, Division of Standards and Conformity Assessment (DSCA), FDA
Vicki Petrides, MS, Quality Program Manager, Abbott
Supporting Resources
CLSI EP10IG
Preliminary Evaluation of Quantitative Medical Laboratory Measurement Procedures Implementation Guide
Companion
Method Evaluation
Free